Product code QPL— Neurology
Axon Therapy
- Classification name
- Electromagnetic Stimulator, Pain Relief
- Device class
- Class 2
- Regulation
- 21 CFR 882.5890
- Advisory panel
- Neurology
- Total cleared
- 6
- First cleared
- Most recent
FDA classification definition
“Intended to apply a magnetic-field induced electrical current to treat pain.”
Market context for product code QPL
FDA has cleared devices under product code QPL between 2021 and 2025, filed by 5 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.
Clearances per year
- 2025
- 2024
- 2023
- 2021
Top applicants under product code QPL
Recent clearances under product code QPL
- K250309 — BTL-199
- K250286 — Rapid2 Magnetic Stimulators (Magstim Rapid2, Magstim Super Rapid2, Magstim Super Rapid2 Plus1)
- K241785 — StarFormer (M008-3T)
- K233364 — Axon Therapy
- K230014 — MagVenture Pain Therapy: MagPro R30, MagPro R30 with MagOption, MagPro X100, MagPro X100 with MagOption
- K210021 — Axon Therapy
Data sourced from openFDA. This site is unofficial and independent of the FDA.